Generic drugs: benefit/risk ratio | Ushkalova | Neurology, Neuropsychiatry, Psychosomatics

Neurology, Neuropsychiatry, Psychosomatics
Nevrologiâ, nejropsihiatriâ, psihosomatika

eng | рус

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)

Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Archives

Download this PDF file

For citations:

Ushkalova E.A., Zyryanov S.K., Gopienko I.A. Generic drugs: benefit/risk ratio. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):98-104. (In Russ.) https://doi.org/10.14412/2074-2711-2021-6-98-104

Views: 119

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)

Popular articles

Editor-in-Chief

Parfenov V.A.

Article Tools

How to cite item

Email this article (Login required)

Email the author (Login required)

About the Authors

E. A. Ushkalova
Peoples' Friendship University of Russia (RUDN University)
Russian Federation

6, Miklukho-Maklai St., Moscow 117198, Russia

S. K. Zyryanov
Peoples' Friendship University of Russia (RUDN University) City Clinical Hospital Twenty-Four, Moscow Healthcare Department
Russian Federation

6, Miklukho-Maklai St., Moscow 117198, Russia

10, Pistsovaya St., Moscow 127015, Russia

I. A. Gopienko
Peoples' Friendship University of Russia (RUDN University)
Russian Federation

6, Miklukho-Maklai St., Moscow 117198, Russia

Notifications